Tag archive for ‘Jonathan Kreizman’
Koby Yeshayahou On Wednesday, December 17th, 2014

Brokerage Upgrades Teva Recommendation following Copaxone Dosage Change

– “We are upgrading our recommendation for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) from “Market perform” to “Market outperform” with a target price of More...

Shiri Habib-Valdhorn On Monday, September 1st, 2014

EZchip jumps on acquistion speculation

– Bank of Jerusalem’s Jonathan Kreizman: The likelihood that the company will be sold is not great. –   Will EZchip Semiconductor Ltd. (Nasdaq: EZCH; TASE:EZCH) be sold to a global technology More...

Wordpress site Developed by Fixing WordPress Problems